Metabolites
Displaying metabolites 2751 - 2775 of 3755 in total
Metabolite ID | Name CAS Number | IUPAC Name | SMPDB Pathways | Weight Formula | Structure |
---|---|---|---|---|---|
ECMDB21000 | D-Urobilinogen 17208-65-0 | 3-(2-{[3-(2-carboxyethyl)-5-[(4-ethenyl-3-methyl-5-oxo-2,5-dihydro-1H-pyrrol-2-yl)methyl]-4-methyl-1H-pyrrol-2-yl]methyl}-5-[(3-ethyl-4-methyl-5-oxo-2,5-dihydro-1H-pyrrol-2-yl)methyl]-4-methyl-1H-pyrrol-3-yl)propanoic acid | 590.7098 C33H42N4O6 | ||
ECMDB20622 | XDP | [({[(2R,3S,4R,5R)-5-(2,6-dihydroxy-9H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}(hydroxy)phosphoryl)oxy]phosphonic acid | Collection of Reactions without pathways PW001891 | 444.1853 C10H14N4O12P2 | |
ECMDB20621 | UDP-N-Acetylmuramoyl-L-alanyl-D-glutamyl-meso-2,6-diaminoheptanedioate-D-alanine | 1-[(2R,3R,4S,5R)-5-{[({[(2R,3R,4R,5S,6R)-4-[(1R)-1-{[(1S)-1-{[(1R)-3-{[(1S,5R)-5-amino-5-carboxy-1-{[(1R)-1-carboxyethyl]-C-hydroxycarbonimidoyl}pentyl]carboximidato}-1-carboxypropyl]-C-hydroxycarbonimidoyl}ethyl]-C-hydroxycarbonimidoyl}ethoxy]-5-hydroxy-6-(hydroxymethyl)-3-[(1-oxidoethylidene)amino]oxan-2-yl phosphonato]oxy}phosphinato)oxy]methyl}-3,4-dihydroxyoxolan-2-yl]-4-hydroxy-2-oxo-2,5-dihydro-1λ⁵-pyrimidine-1,5-bis(ylium) | 1118.8362 C38H56N8O27P2 | ||
ECMDB20620 | Ubiquinone-6 1065-31-2 | 2-[(2E,6E,10E,14E,18E)-3,7,11,15,19,23-hexamethyltetracosa-2,6,10,14,18,22-hexaen-1-yl]-5,6-dimethoxy-3-methylcyclohexa-2,5-diene-1,4-dione | TCA cycle (ubiquinol-6) PW001006 | 590.8754 C39H58O4 | |
ECMDB20619 | Ubiquinol-10 5677-55-4 | 2-[(2E,6E,10E,14E,18E,22E,26E,30E,34E)-3,7,11,15,19,23,27,31,35,39-decamethyltetraconta-2,6,10,14,18,22,26,30,34,38-decaen-1-yl]-5,6-dimethoxy-3-methylcyclohexa-2,5-diene-1,4-diol | TCA cycle (ubiquinol-10) PW001010 | 865.3594 C59H92O4 | |
ECMDB20613 | dTDP-4-Acetamido-4,6-dideoxy-D-galactose | {[(3R,4S,6R)-5-acetamido-3,4-dihydroxy-6-methyloxan-2-yl]oxy}({[hydroxy({[3-hydroxy-5-(5-methyl-2,4-dioxo-1,2,3,4-tetrahydropyrimidin-1-yl)oxolan-2-yl]methoxy})phosphoryl]oxy})phosphinic acid | Secondary Metabolites: enterobacterial common antigen biosynthesis 3 PW002046 | 589.3815 C18H29N3O15P2 | |
ECMDB20612 | dTDP-D-Fucosamine | [({[(2R,3R,4S,5R,6R)-5-amino-3,4-dihydroxy-6-methyloxan-2-yl]oxy}(hydroxy)phosphoryl)oxy]({[3-hydroxy-5-(4-hydroxy-5-methyl-2-oxo-1,2-dihydropyrimidin-1-yl)oxolan-2-yl]methoxy})phosphinic acid | Secondary Metabolites: enterobacterial common antigen biosynthesis 3 PW002046 | 547.3448 C16H27N3O14P2 | |
ECMDB20611 | trans-Delta2, cis-delta4-decadienoyl-CoA | 4-({[({[(2S,3S,4R,5S)-5-(6-amino-9H-purin-9-yl)-4-hydroxy-3-(phosphonooxy)oxolan-2-yl]methoxy}(hydroxy)phosphoryl)oxy](hydroxy)phosphoryl}oxy)-N-(2-{[2-(deca-2,4-dienoylsulfanyl)ethyl]-C-hydroxycarbonimidoyl}ethyl)-2-hydroxy-3,3-dimethylbutanimidic acid | 917.75 C31H50N7O17P3S | ||
ECMDB20610 | Sn-Glycerol-1-phosphate 5746-57-6 | [(2S)-2,3-dihydroxypropoxy]phosphonic acid | 172.0737 C3H9O6P | ||
ECMDB20608 | L-Seryl-AMP 52435-67-3 | {[(2S)-2-amino-3-hydroxypropanoyl]oxy}({[(2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy})phosphinic acid | 434.2985 C13H19N6O9P | ||
ECMDB20604 | S-Carboxymethyl-D-cysteine | 2-[(2-amino-2-carboxyethyl)sulfanyl]acetate | 178.186 C5H8NO4S | ||
ECMDB20601 | Cyclic pyranopterin monophosphate | (4aR,5aR,11aR,12aS)-2,10,12,12-tetrahydroxy-8-imino-4,4a,5a,6,7,8,11,11a,12,12a-decahydro-2H-1,3,5-trioxa-6,7,9,11-tetraaza-2lambda5-phosphatetracen-2-one | 363.2206 C10H14N5O8P | ||
ECMDB20599 | Phenylhydantoin 89-24-7 | 4-phenyl-4H-imidazole-2,5-diol | Collection of Reactions without pathways PW001891 | 176.172 C9H8N2O2 | |
ECMDB20598 | Phenylglyoxal 1074-12-0 | 2-oxo-2-phenylacetaldehyde | 134.132 C8H6O2 | ||
ECMDB20594 | NMNH | 1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-[(phosphonooxy)methyl]oxolan-2-yl]-1,4-dihydropyridine-3-carboximidic acid | 336.235 C11H17N2O8P | ||
ECMDB20591 | N3-Methylcytosine | 6-amino-1-methyl-2-oxo-2,3-dihydropyrimidin-1-ium | 126.1365 C5H8N3O | ||
ECMDB20590 | N1-Methyladenine 5142-22-3 | 1-methyl-6,9-dihydro-1H-purin-6-imine | 149.1533 C6H7N5 | ||
ECMDB20581 | L-Glyceraldehyde 3-phosphate | {[(2S)-2-hydroxy-3-oxopropoxy]dioxo-λ⁵-phosphanuidyl}oxidanyl | 168.042 C3H5O6P | ||
ECMDB20580 | L-Glyceraldehyde 497-09-6 | (2S)-2,3-dihydroxypropanal | 90.0779 C3H6O3 | ||
ECMDB20579 | Linear dimeric GMP | 9-[(2R,3R,4S,5R)-4-[({[(2R,3S,4R,5R)-3,4-dihydroxy-5-(2-imino-6-oxido-3,9-dihydro-2H-purin-9-yl)oxolan-2-yl]methoxy}(hydroxy)phosphoryl)oxy]-5-[(hydrogen phosphonatooxy)methyl]-3-hydroxyoxolan-2-yl]-2-imino-3,9-dihydro-2H-purin-6-olate | 705.4021 C20H23N10O15P2 | ||
ECMDB20578 | L-Carnitinyl-CoA | [4-({2-[(3-{[4-({[({[5-(6-amino-9H-purin-9-yl)-4-hydroxy-3-(phosphonooxy)oxolan-2-yl]methoxy}(hydroxy)phosphoryl)oxy](hydroxy)phosphoryl}oxy)-1,2-dihydroxy-3,3-dimethylbutylidene]amino}-1-hydroxypropylidene)amino]ethyl}sulfanyl)-2-hydroxy-4-oxobutyl]trimethylazanium | 911.726 C28H50N8O18P3S | ||
ECMDB20576 | L-Ara4N-modified KDO2-Lipid A | 2-{[3-({[(5-amino-3,4-dihydroxyoxan-2-yl)oxy](hydroxy)phosphoryl}oxy)-6-{[6-({[(5-amino-3,4-dihydroxyoxan-2-yl)oxy](hydroxy)phosphoryl}oxy)-5-[(1,3-dihydroxytetradecylidene)amino]-3-hydroxy-4-[(3-hydroxytetradecanoyl)oxy]oxan-2-yl]methoxy}-5-{[3-(dodecanoyloxy)-1-hydroxytetradecylidene]amino}-4-{[3-(tetradecanoyloxy)tetradecanoyl]oxy}oxan-2-yl]methoxy}-4-{[2-carboxy-6-(1,2-dihydroxyethyl)-4,5-dihydroxyoxan-2-yl]oxy}-6-(1,2-dihydroxyethyl)-5-hydroxyoxane-2-carboxylic acid | polymyxin resistance PW002052 | 2500.9781 C120H220N4O45P2 | |
ECMDB20575 | L-Ala-gamma-D-Glu-Dap | 4-[(2-amino-1-hydroxypropylidene)amino]-4-[(6-imino-1,6-dihydropyridin-2-yl)-C-hydroxycarbonimidoyl]butanoic acid | 309.3211 C13H19N5O4 | ||
ECMDB20574 | L-Ala-gamma-D-Glu | (4R)-4-{[(2S)-2-amino-1-hydroxypropylidene]amino}-4-carboxybutanoate | 217.1992 C8H13N2O5 | ||
ECMDB20573 | L-Ala-D-Glu-meso-A2pm | (2R,6S)-2-amino-6-{[(4R)-4-{[(2S)-2-amino-1-hydroxypropylidene]amino}-4-carboxy-1-hydroxybutylidene]amino}heptanedioic acid | 390.3889 C15H26N4O8 |